UK Markets closed

4basebio PLC (4BB.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
685.00+5.00 (+0.74%)
At close: 2:48PM BST
Currency in GBp

Valuation measures

Market cap (intra-day) 584.37M
Enterprise value 380.31M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)182.63
Price/book (mrq)N/A
Enterprise value/revenue 3173.83
Enterprise value/EBITDA 7-138.46

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3789.00
52-week low 3175.00
50-day moving average 3679.75
200-day moving average 3462.47

Share statistics

Avg vol (3-month) 37.28k
Avg vol (10-day) 31.41k
Shares outstanding 512.32M
Implied shares outstanding 6N/A
Float 3.51M
% held by insiders 162.12%
% held by institutions 16.09%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)N/A


Profit margin -155.63%
Operating margin (ttm)-134.63%

Management effectiveness

Return on assets (ttm)-4.10%
Return on equity (ttm)-10.60%

Income statement

Revenue (ttm)462k
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)274k
EBITDA -580k
Net income avi to common (ttm)-719k
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)19.08
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-1.02M
Levered free cash flow (ttm)-712.5k